A core facility for advancing kidney disease treatments
Official title: Applied Systems Biology Core
Funded at University of Michigan at Ann Arbor · NIH-10914999 · Data updated 2026-11-12
This study is all about finding new ways to treat kidney diseases by looking closely at genetic information, and it’s designed to help patients like you by discovering better treatments tailored to your needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $244,684 |
| NIH project number | 5U54DK137314-02 |
| Project ID | NIH-10914999 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with acute or chronic kidney diseases.
✕Less likely to help
Patients with kidney diseases that are not well-defined or do not fit into the categories being studied may not receive benefit from this research.
What this research studies
The Applied Systems Biology Core (ASBC) at the Michigan O'Brien Kidney Translational Resource Center focuses on developing innovative treatment strategies for patients with acute and chronic kidney diseases. This research involves expert consulting services that help investigators analyze large-scale genomic data related to kidney health. By integrating biological and clinical knowledge, the ASBC aims to identify molecular markers and critical pathways that can lead to better understanding and treatment of kidney conditions. Patients may benefit from the insights gained through this research as it supports the development of targeted therapies.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from kidney diseases.
How similar studies have gone: Other research initiatives utilizing systems biology approaches have shown promise in advancing treatment strategies for various diseases, indicating a potential for success in this area as well.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Kretzler, Matthias — University of Michigan at Ann Arbor
- Study coordinator: Kretzler, Matthias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.